STAT3 and cancer: However, inhibitors for such MRs can be inferred from gene expression data of appropriate models after drug perturbation, as we have shown here for MYC and STAT3. We can envision a framework for cancer precision medicine in which we first infer the MRs for a single-patient in an unbias genome-wide fashion.